1. Li C, Wang H, Chen R, Zhang H, Xu Y, Zhang B, Li Y, Zhang C, Yang Y, Wang X and Li X. Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging. Am J Cancer Res 2022; 12: 907-921.
2. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy;AG;Nat Rev Clin Oncol,2023
3. Hepatocellular carcinoma;Vogel;Lancet,2022
4. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability;KA;Clin Liver Dis,2015
5. Liu X, Zhang P, Martin RC, Cui G, Wang G, Tan Y, Cai L, Lv G and Li Y. Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice. Am J Cancer Res 2016; 6: 1011-1025.